vs
Encompass Health Corp（EHC）与ENSIGN GROUP, INC（ENSG）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是ENSIGN GROUP, INC的1.1倍（$1.5B vs $1.3B），Encompass Health Corp净利率更高（9.5% vs 7.1%，领先2.4%），ENSIGN GROUP, INC同比增速更快（19.0% vs 9.9%），过去两年ENSIGN GROUP, INC的营收复合增速更高（15.5% vs 8.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
Ensign Energy Services Inc.是加拿大上市油田服务提供商，成立于1987年，总部位于阿尔伯塔省卡尔加里，业务覆盖北美及全球多个市场，公司普通股在多伦多证券交易所挂牌交易，交易代码为ESI。
EHC vs ENSG — 直观对比
营收规模更大
EHC
是对方的1.1倍
$1.3B
营收增速更快
ENSG
高出9.1%
9.9%
净利率更高
EHC
高出2.4%
7.1%
两年增速更快
ENSG
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.3B |
| 净利润 | $146.1M | $95.5M |
| 毛利率 | — | 20.3% |
| 营业利润率 | 16.7% | 9.2% |
| 净利率 | 9.5% | 7.1% |
| 营收同比 | 9.9% | 19.0% |
| 净利润同比 | 20.8% | 19.8% |
| 每股收益（稀释后） | $1.43 | $1.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCENSG
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.5B | $1.2B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.4B | $1.1B | ||
| Q2 24 | $1.3B | $1.0B | ||
| Q1 24 | $1.3B | $1.0B |
净利润EHCENSG
| Q4 25 | $146.1M | $95.5M | ||
| Q3 25 | $126.5M | $83.8M | ||
| Q2 25 | $142.1M | $84.4M | ||
| Q1 25 | $151.5M | $80.3M | ||
| Q4 24 | $120.9M | $79.7M | ||
| Q3 24 | $108.2M | $78.4M | ||
| Q2 24 | $114.1M | $71.0M | ||
| Q1 24 | $112.5M | $68.8M |
毛利率EHCENSG
| Q4 25 | — | 20.3% | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 20.4% | ||
| Q1 25 | — | 20.9% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | — | 20.5% | ||
| Q2 24 | — | 20.8% | ||
| Q1 24 | — | 20.9% |
营业利润率EHCENSG
| Q4 25 | 16.7% | 9.2% | ||
| Q3 25 | 14.9% | 7.5% | ||
| Q2 25 | 16.2% | 8.5% | ||
| Q1 25 | 16.4% | 8.6% | ||
| Q4 24 | 14.3% | 8.9% | ||
| Q3 24 | 13.6% | 8.3% | ||
| Q2 24 | 14.3% | 8.3% | ||
| Q1 24 | 13.6% | 8.1% |
净利率EHCENSG
| Q4 25 | 9.5% | 7.1% | ||
| Q3 25 | 8.6% | 6.5% | ||
| Q2 25 | 9.7% | 6.9% | ||
| Q1 25 | 10.4% | 6.8% | ||
| Q4 24 | 8.6% | 7.0% | ||
| Q3 24 | 8.0% | 7.3% | ||
| Q2 24 | 8.8% | 6.9% | ||
| Q1 24 | 8.5% | 6.8% |
每股收益（稀释后）EHCENSG
| Q4 25 | $1.43 | $1.61 | ||
| Q3 25 | $1.24 | $1.42 | ||
| Q2 25 | $1.39 | $1.44 | ||
| Q1 25 | $1.48 | $1.37 | ||
| Q4 24 | $1.18 | $1.37 | ||
| Q3 24 | $1.06 | $1.34 | ||
| Q2 24 | $1.12 | $1.22 | ||
| Q1 24 | $1.10 | $1.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $572.4M |
| 总债务越低越好 | $2.4B | $144.4M |
| 股东权益账面价值 | $2.4B | $2.2B |
| 总资产 | $7.1B | $5.5B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资EHCENSG
| Q4 25 | $72.2M | $572.4M | ||
| Q3 25 | $48.7M | $506.3M | ||
| Q2 25 | $99.1M | $418.4M | ||
| Q1 25 | $95.8M | $344.5M | ||
| Q4 24 | $85.4M | $526.9M | ||
| Q3 24 | $147.8M | $571.0M | ||
| Q2 24 | $154.4M | $501.5M | ||
| Q1 24 | $134.4M | $526.3M |
总债务EHCENSG
| Q4 25 | $2.4B | $144.4M | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $148.4M | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益EHCENSG
| Q4 25 | $2.4B | $2.2B | ||
| Q3 25 | $2.4B | $2.1B | ||
| Q2 25 | $2.3B | $2.0B | ||
| Q1 25 | $2.2B | $1.9B | ||
| Q4 24 | $2.1B | $1.8B | ||
| Q3 24 | $2.0B | $1.7B | ||
| Q2 24 | $1.8B | $1.7B | ||
| Q1 24 | $1.7B | $1.6B |
总资产EHCENSG
| Q4 25 | $7.1B | $5.5B | ||
| Q3 25 | $6.9B | $5.2B | ||
| Q2 25 | $6.8B | $4.9B | ||
| Q1 25 | $6.6B | $4.8B | ||
| Q4 24 | $6.5B | $4.7B | ||
| Q3 24 | $6.5B | $4.6B | ||
| Q2 24 | $6.4B | $4.4B | ||
| Q1 24 | $6.2B | $4.3B |
负债/权益比EHCENSG
| Q4 25 | 1.00× | 0.06× | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | 0.08× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $183.3M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | — |
| 自由现金流率自由现金流/营收 | 7.6% | — |
| 资本支出强度资本支出/营收 | 14.8% | — |
| 现金转化率经营现金流/净利润 | 2.37× | 1.92× |
| 过去12个月自由现金流最近4个季度 | $439.2M | — |
8季度趋势，按日历期对齐
经营现金流EHCENSG
| Q4 25 | $346.0M | $183.3M | ||
| Q3 25 | $270.8M | $153.0M | ||
| Q2 25 | $270.2M | $155.7M | ||
| Q1 25 | $288.6M | $72.2M | ||
| Q4 24 | $278.8M | $100.5M | ||
| Q3 24 | $267.8M | $134.5M | ||
| Q2 24 | $217.4M | $76.9M | ||
| Q1 24 | $238.8M | $35.3M |
自由现金流EHCENSG
| Q4 25 | $116.7M | — | ||
| Q3 25 | $83.7M | — | ||
| Q2 25 | $113.3M | — | ||
| Q1 25 | $125.5M | — | ||
| Q4 24 | $80.1M | — | ||
| Q3 24 | $120.3M | — | ||
| Q2 24 | $60.5M | — | ||
| Q1 24 | $99.4M | — |
自由现金流率EHCENSG
| Q4 25 | 7.6% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 7.8% | — | ||
| Q1 25 | 8.6% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 4.6% | — | ||
| Q1 24 | 7.6% | — |
资本支出强度EHCENSG
| Q4 25 | 14.8% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 10.9% | — | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | 10.6% | — |
现金转化率EHCENSG
| Q4 25 | 2.37× | 1.92× | ||
| Q3 25 | 2.14× | 1.82× | ||
| Q2 25 | 1.90× | 1.85× | ||
| Q1 25 | 1.90× | 0.90× | ||
| Q4 24 | 2.31× | 1.26× | ||
| Q3 24 | 2.48× | 1.71× | ||
| Q2 24 | 1.91× | 1.08× | ||
| Q1 24 | 2.12× | 0.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
ENSG
| Skilled Services Segment | $1.3B | 97% |
| Standard Bearer Segment | $34.5M | 3% |
